{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T17:46:34Z","timestamp":1791740794896,"version":"4.3.4"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"DOI":"10.1007\/s10620-026-10272-6","type":"journal-article","created":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T17:12:43Z","timestamp":1791738763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gastric Intestinal Metaplasia After Helicobacter pylori Eradication: Reframing the Reversibility Controversy"],"prefix":"10.1007","author":[{"given":"Kunlin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhou","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowei","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,11]]},"reference":[{"key":"10272_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"10272_CR2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/ijc.28999","volume":"136","author":"M Plummer","year":"2015","unstructured":"Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer 2015;136:487\u2013490. https:\/\/doi.org\/10.1002\/ijc.28999.","journal-title":"Int J Cancer"},{"key":"10272_CR3","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.cgh.2024.02.023","volume":"22","author":"DT M\u00fclder","year":"2024","unstructured":"M\u00fclder DT, Hahn AI, Huang RJ et al. Prevalence of gastric precursor lesions in countries with differential gastric cancer burden: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2024;22:1605\u20131617. https:\/\/doi.org\/10.1016\/j.cgh.2024.02.023.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10272_CR4","first-page":"6735","volume":"52","author":"P Correa","year":"1992","unstructured":"Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res 1992;52:6735\u20136740.","journal-title":"Cancer Res"},{"key":"10272_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1751-2980.2011.00550.x","volume":"13","author":"P Correa","year":"2012","unstructured":"Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis 2012;13:2\u20139. https:\/\/doi.org\/10.1111\/j.1751-2980.2011.00550.x.","journal-title":"J Dig Dis"},{"key":"10272_CR6","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","volume":"71","author":"P Malfertheiner","year":"2022","unstructured":"Malfertheiner P, Megraud F, Rokkas T et al. Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report. Gut 2022;71:1724\u20131762. https:\/\/doi.org\/10.1136\/gutjnl-2022-327745.","journal-title":"Gut"},{"key":"10272_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1055\/a-0859-1883","volume":"51","author":"P Pimentel-Nunes","year":"2019","unstructured":"Pimentel-Nunes P, Lib\u00e2nio D, Marcos-Pinto R et al. Management of epithelial precancerous conditions and lesions in the stomach (maps II): European Society of gastrointestinal endoscopy (ESGE), European Helicobacter and microbiota Study Group (EHMSG), European Society of pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update. Endoscopy 2019;51:365\u2013388.","journal-title":"Endoscopy"},{"key":"10272_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10120-015-0462-7","volume":"19","author":"HN Chen","year":"2016","unstructured":"Chen HN, Wang Z, Li X, Zhou ZG. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Gastric Cancer 2016;19:166\u2013175. https:\/\/doi.org\/10.1007\/s10120-015-0462-7.","journal-title":"Gastric Cancer"},{"key":"10272_CR9","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1136\/gutjnl-2020-320839","volume":"69","author":"AC Ford","year":"2020","unstructured":"Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut 2020;69:2113\u20132121. https:\/\/doi.org\/10.1136\/gutjnl-2020-320839.","journal-title":"Gut"},{"key":"10272_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/gutjnl-2020-322200","volume":"70","author":"TH Chiang","year":"2021","unstructured":"Chiang TH, Chang WJ, Chen SL et al. Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands. Gut 2021;70:243\u2013250. https:\/\/doi.org\/10.1136\/gutjnl-2020-322200.","journal-title":"Gut"},{"key":"10272_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/nejmoa1909666","volume":"382","author":"IJ Choi","year":"2020","unstructured":"Choi IJ, Kim CG, Lee JY et al. Family history of gastric cancer and Helicobacter pylori treatment. N Engl J Med 2020;382:427\u2013436. https:\/\/doi.org\/10.1056\/nejmoa1909666.","journal-title":"N Engl J Med"},{"key":"10272_CR12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2478\/raon-2024-0028","volume":"58","author":"J Drnov\u0161ek","year":"2024","unstructured":"Drnov\u0161ek J, Homan M, Zidar N, \u0160mid LM. Pathogenesis and potential reversibility of intestinal metaplasia \u2013 a milestone in gastric carcinogenesis. Radiol Oncol 2024;58:186\u2013195. https:\/\/doi.org\/10.2478\/raon-2024-0028.","journal-title":"Radiol Oncol"},{"key":"10272_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/gidisord8010010","volume":"8","author":"J Chen","year":"2026","unstructured":"Chen J, Xu H, Feng Y, Shen H. Advances in reversing gastric mucosal atrophy: pathological mechanisms, therapeutic targets, and clinical strategies. Gastrointest Disord 2026;8:10. https:\/\/doi.org\/10.3390\/gidisord8010010.","journal-title":"Gastrointest Disord"},{"key":"10272_CR14","doi-asserted-by":"publisher","first-page":"1779490","DOI":"10.3389\/fmicb.2026.1779490","volume":"17","author":"L Song","year":"2026","unstructured":"Song L, Yu QY. Stratified management of residual gastric cancer risk after Helicobacter pylori eradication. Front Microbiol 2026;17:1779490. https:\/\/doi.org\/10.3389\/fmicb.2026.1779490.","journal-title":"Front Microbiol"},{"key":"10272_CR15","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","volume":"20","author":"MF Dixon","year":"1996","unstructured":"Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. Am J Surg Pathol 1996;20:1161\u20131181. https:\/\/doi.org\/10.1097\/00000478-199610000-00001.","journal-title":"Am J Surg Pathol"},{"key":"10272_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/s0046-8177(99)90303-9","volume":"30","author":"HM El-Zimaity","year":"1999","unstructured":"El-Zimaity HM, Graham DY. Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System. Hum Pathol 1999;30:72\u201377. https:\/\/doi.org\/10.1016\/s0046-8177(99)90303-9.","journal-title":"Hum Pathol"},{"key":"10272_CR17","doi-asserted-by":"publisher","first-page":"e00402","DOI":"10.14309\/ctg.0000000000000402","volume":"12","author":"S Du","year":"2021","unstructured":"Du S, Yang Y, Fang S et al. Gastric cancer risk of intestinal metaplasia subtypes: a systematic review and meta-analysis of cohort studies. Clin Transl Gastroenterol 2021;12:e00402. https:\/\/doi.org\/10.14309\/ctg.0000000000000402.","journal-title":"Clin Transl Gastroenterol"},{"key":"10272_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12935-021-01869-0","volume":"21","author":"N Wei","year":"2021","unstructured":"Wei N, Zhou M, Lei S et al. A meta-analysis and systematic review on subtypes of gastric intestinal metaplasia and neoplasia risk. Cancer Cell Int 2021;21:173. https:\/\/doi.org\/10.1186\/s12935-021-01869-0.","journal-title":"Cancer Cell Int"},{"key":"10272_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","volume":"4","author":"C Baethge","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA\u2014a scale for the quality assessment of narrative review articles. Res Integr Peer Rev 2019;4:5. https:\/\/doi.org\/10.1186\/s41073-019-0064-8.","journal-title":"Res Integr Peer Rev"},{"key":"10272_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1523-5378.2007.00563.x","volume":"12","author":"T Rokkas","year":"2007","unstructured":"Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis. Helicobacter 2007;12:32\u201338. https:\/\/doi.org\/10.1111\/j.1523-5378.2007.00563.x.","journal-title":"Helicobacter"},{"key":"10272_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000280318","volume":"83","author":"J Wang","year":"2011","unstructured":"Wang J, Xu L, Shi R, Huang X, Li SWH, Huang Z, Zhang G. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion 2011;83:253\u2013260. https:\/\/doi.org\/10.1159\/000280318.","journal-title":"Digestion"},{"key":"10272_CR22","doi-asserted-by":"publisher","first-page":"5903","DOI":"10.3748\/wjg.v20.i19.5903","volume":"20","author":"YJ Kong","year":"2014","unstructured":"Kong YJ, Yi HG, Dai JC, Wei MX. Histological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysis. World J Gastroenterol 2014;20:5903\u20135911. https:\/\/doi.org\/10.3748\/wjg.v20.i19.5903.","journal-title":"World J Gastroenterol"},{"key":"10272_CR23","doi-asserted-by":"publisher","first-page":"e13013","DOI":"10.1111\/hel.13013","volume":"28","author":"F Zhu","year":"2023","unstructured":"Zhu F, Zhang X, Li P, Zhu Y. Effect of Helicobacter pylori eradication on gastric precancerous lesions: a systematic review and meta-analysis. Helicobacter 2023;28:e13013. https:\/\/doi.org\/10.1111\/hel.13013.","journal-title":"Helicobacter"},{"key":"10272_CR24","doi-asserted-by":"publisher","first-page":"e13042","DOI":"10.1111\/hel.13042","volume":"29","author":"Y Liang","year":"2023","unstructured":"Liang Y, Yang Y, Nong R, Huang H, Chen X, Deng Y, Huang Z, Huang J, Cheng C, Ji M, Chen Y, Hu F. Do atrophic gastritis and intestinal metaplasia reverse after Helicobacter pylori eradication? Helicobacter 2023;29:e13042. https:\/\/doi.org\/10.1111\/hel.13042.","journal-title":"Helicobacter"},{"key":"10272_CR25","doi-asserted-by":"publisher","first-page":"1530549","DOI":"10.3389\/fmicb.2025.1530549","volume":"16","author":"Q Fu","year":"2025","unstructured":"Fu Q, Yu H, Liu M, Chen L, Chen W, Wang Z, Li W. Effect of Helicobacter pylori eradication on gastric cancer risk in patients with intestinal metaplasia or dysplasia: a meta-analysis of randomized controlled trials. Front Microbiol 2025;16:1530549. https:\/\/doi.org\/10.3389\/fmicb.2025.1530549.","journal-title":"Front Microbiol"},{"key":"10272_CR26","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1136\/gutjnl-2024-333684","volume":"74","author":"DY Graham","year":"2025","unstructured":"Graham DY, Lee YC. Commentary on: the management of patients with gastric intestinal metaplasia. Gut 2025;74:699\u2013700. https:\/\/doi.org\/10.1136\/gutjnl-2024-333684.","journal-title":"Gut"},{"key":"10272_CR27","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/j.gastro.2019.12.003","volume":"158","author":"S Gupta","year":"2020","unstructured":"Gupta S, Li D, El Serag HB et al. AGA clinical practice guidelines on management of gastric intestinal metaplasia. Gastroenterology 2020;158:693\u2013702. https:\/\/doi.org\/10.1053\/j.gastro.2019.12.003.","journal-title":"Gastroenterology"},{"key":"10272_CR28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jfma.2022.11.008","volume":"122","author":"HC Cheng","year":"2023","unstructured":"Cheng HC, Yang YJ, Yang HB et al. Evolution of the Correa\u2019s cascade steps: a long-term endoscopic surveillance among non-ulcer dyspepsia and gastric ulcer after H. pylori eradication. J Formos Med Assoc 2023;122:400\u2013410. https:\/\/doi.org\/10.1016\/j.jfma.2022.11.008.","journal-title":"J Formos Med Assoc"},{"key":"10272_CR29","doi-asserted-by":"publisher","first-page":"e70139","DOI":"10.1111\/hel.70139","volume":"31","author":"YI Kim","year":"2026","unstructured":"Kim YI, Lee JY, Kim CG, Kook MC, Park B, Choi IJ. Long-term effect of Helicobacter pylori eradication on gastric atrophy and intestinal metaplasia after endoscopic resection of gastric neoplasm: a follow-up of a randomized controlled trial. Helicobacter 2026;31:e70139. https:\/\/doi.org\/10.1111\/hel.70139.","journal-title":"Helicobacter"},{"key":"10272_CR30","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.3390\/cancers16244153","volume":"16","author":"R Abe","year":"2024","unstructured":"Abe R, Uchikoshi S, Horikawa Y et al. Endoscopic and histological characteristics of gastric cancer detected long after Helicobacter pylori eradication therapy. Cancers 2024;16:4153. https:\/\/doi.org\/10.3390\/cancers16244153.","journal-title":"Cancers"},{"key":"10272_CR31","doi-asserted-by":"publisher","first-page":"e70086","DOI":"10.1002\/deo2.70086","volume":"5","author":"M Kodama","year":"2025","unstructured":"Kodama M, Handa O, Sugimoto M et al. Endoscopic risk factors to inform early detection of gastric cancer after Helicobacter pylori eradication: meta-analysis and systematic review. DEN Open 2025;5:e70086. https:\/\/doi.org\/10.1002\/deo2.70086.","journal-title":"DEN Open"},{"key":"10272_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/cancers17010128","volume":"17","author":"J Drnov\u0161ek","year":"2025","unstructured":"Drnov\u0161ek J, Zidar N, Jeruc J et al. Gastric intestinal metaplasia in children and adolescents is reversible upon reaching adulthood \u2014 results from a long-term cohort study. Cancers 2025;17:128. https:\/\/doi.org\/10.3390\/cancers17010128.","journal-title":"Cancers"},{"key":"10272_CR33","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1053\/j.gastro.2020.11.017","volume":"160","author":"MB Piazuelo","year":"2021","unstructured":"Piazuelo MB, Bravo LE, Mera RM et al. The Colombian chemoprevention trial: 20-year follow-up of a cohort of patients with gastric precancerous lesions. Gastroenterology 2021;160:1106-1117.e3. https:\/\/doi.org\/10.1053\/j.gastro.2020.11.017.","journal-title":"Gastroenterology"},{"key":"10272_CR34","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/jgh.70214","volume":"41","author":"Y Huang","year":"2025","unstructured":"Huang Y, Xie S, Yan C, Zhang J. Neutrophil-mediated mechanisms and therapeutic reversibility of gastric intestinal metaplasia. J Gastroenterol Hepatol 2025;41:586\u2013605. https:\/\/doi.org\/10.1111\/jgh.70214.","journal-title":"J Gastroenterol Hepatol"},{"key":"10272_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/gutjnl-2025-335329","volume":"75","author":"YC Lee","year":"2026","unstructured":"Lee YC. Single-biopsy epigenetic profiling reveals persistent DNA methylation and gastric cancer risk after Helicobacter pylori eradication. Gut 2026;75:2\u20134. https:\/\/doi.org\/10.1136\/gutjnl-2025-335329.","journal-title":"Gut"},{"key":"10272_CR36","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1002\/cam4.1082","volume":"6","author":"S Tahara","year":"2017","unstructured":"Tahara S, Tahara T, Tuskamoto T, Horiguchi N et al. Morphologic characterization of residual DNA methylation in the gastric mucosa after Helicobacter pylori eradication. Cancer Med 2017;6:1730\u20131737. https:\/\/doi.org\/10.1002\/cam4.1082.","journal-title":"Cancer Med"},{"key":"10272_CR37","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1158\/1078-0432.CCR-11-2011","volume":"18","author":"T Ushijima","year":"2012","unstructured":"Ushijima T, Hattori N. Molecular pathways: involvement of Helicobacter pylori-triggered inflammation in the formation of an epigenetic field defect, and its usefulness as cancer risk and exposure markers. Clin Cancer Res 2012;18:923\u2013929. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2011.","journal-title":"Clin Cancer Res"},{"key":"10272_CR38","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrgastro.2017.53","volume":"14","author":"N Padmanabhan","year":"2017","unstructured":"Padmanabhan N, Ushijima T, Tan P. How to stomach an epigenetic insult: the gastric cancer epigenome. Nat Rev Gastroenterol Hepatol 2017;14:467\u2013478. https:\/\/doi.org\/10.1038\/nrgastro.2017.53.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10272_CR39","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/j.1572-0241.2007.01284.x","volume":"102","author":"F Perri","year":"2007","unstructured":"Perri F, Cotugno R, Piepoli A et al. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pylori infected patients and effect of eradication. Am J Gastroenterol 2007;102:1361\u20131371. https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01284.x.","journal-title":"Am J Gastroenterol"},{"key":"10272_CR40","doi-asserted-by":"publisher","first-page":"e12915","DOI":"10.1111\/hel.12915","volume":"27","author":"I Tanaka","year":"2022","unstructured":"Tanaka I, Ono S, Watanabe Y et al. Long-term changes in aberrant DNA methylation and gastritis after Helicobacter pylori eradication focused on metachronous gastric cancer. Helicobacter 2022;27:e12915. https:\/\/doi.org\/10.1111\/hel.12915.","journal-title":"Helicobacter"},{"key":"10272_CR41","doi-asserted-by":"publisher","first-page":"12559","DOI":"10.1038\/s41598-019-49069-1","volume":"9","author":"J Watari","year":"2019","unstructured":"Watari J, Ito C, Shimoda T et al. DNA methylation silencing of microRNA gene methylator in the precancerous background mucosa with and without gastric cancer. Sci Rep 2019;9:12559. https:\/\/doi.org\/10.1038\/s41598-019-49069-1.","journal-title":"Sci Rep"},{"key":"10272_CR42","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1073\/pnas.1717340115","volume":"115","author":"S Yamashita","year":"2018","unstructured":"Yamashita S, Kishino T, Takahashi T et al. Genetic and epigenetic alterations in normal tissues have differential impacts on cancer risk among tissues. Proc Natl Acad Sci USA 2018;115:1328\u20131333. https:\/\/doi.org\/10.1073\/pnas.1717340115.","journal-title":"Proc Natl Acad Sci USA"},{"key":"10272_CR43","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/gutjnl-2017-314205","volume":"67","author":"RM Ferreira","year":"2018","unstructured":"Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I et al. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut 2018;67:226\u2013236. https:\/\/doi.org\/10.1136\/gutjnl-2017-314205.","journal-title":"Gut"},{"key":"10272_CR44","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10620-020-06101-z","volume":"65","author":"L Engstrand","year":"2020","unstructured":"Engstrand L, Graham DY. Microbiome and gastric cancer. Dig Dis Sci 2020;65:865\u2013873. https:\/\/doi.org\/10.1007\/s10620-020-06101-z.","journal-title":"Dig Dis Sci"},{"key":"10272_CR45","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1097\/cm9.0000000000003348","volume":"137","author":"Y Li","year":"2024","unstructured":"Li Y, He C, Lu N. Impacts of Helicobacter pylori infection and eradication on gastrointestinal microbiota: an up-to-date critical review. Chin Med J 2024;137:2833\u20132842. https:\/\/doi.org\/10.1097\/cm9.0000000000003348.","journal-title":"Chin Med J"},{"key":"10272_CR46","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1136\/gutjnl-2019-319826","volume":"69","author":"JJY Sung","year":"2020","unstructured":"Sung JJY, Coker OO, Chu E et al. Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication. Gut 2020;69:1572\u20131580. https:\/\/doi.org\/10.1136\/gutjnl-2019-319826.","journal-title":"Gut"},{"key":"10272_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41522-024-00623-4","volume":"11","author":"M Xia","year":"2025","unstructured":"Xia M, Lei L, Zhao L, Xu W, Zhang H, Li M et al. The dynamic oral-gastric microbial axis connects oral and gastric health: current evidence and disputes. npj Biofilms Microbiomes 2025;11:1. https:\/\/doi.org\/10.1038\/s41522-024-00623-4.","journal-title":"npj Biofilms Microbiomes"},{"key":"10272_CR48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13099-026-00805-9","volume":"18","author":"N Renchinsengee","year":"2026","unstructured":"Renchinsengee N, Batsaikhan S, Khangai A, Boldbaatar G, Luvsandagva B, Lazatkhan A et al. Species-level dynamics of gastric microbiome after Helicobacter pylori eradication in high-risk Mongolian population. Gut Pathogens 2026;18:14. https:\/\/doi.org\/10.1186\/s13099-026-00805-9.","journal-title":"Gut Pathogens"},{"key":"10272_CR49","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1136\/gutjnl-2017-314281","volume":"67","author":"OO Coker","year":"2018","unstructured":"Coker OO, Dai Z, Nie Y et al. Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut 2018;67:1024\u20131032. https:\/\/doi.org\/10.1136\/gutjnl-2017-314281.","journal-title":"Gut"},{"key":"10272_CR50","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1136\/gutjnl-2019-319696","volume":"69","author":"Y Guo","year":"2020","unstructured":"Guo Y, Zhang Y, Gerhard M et al. Effect of Helicobacter pylori on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer. Gut 2020;69:1598\u20131607. https:\/\/doi.org\/10.1136\/gutjnl-2019-319696.","journal-title":"Gut"},{"key":"10272_CR51","doi-asserted-by":"publisher","first-page":"1592977","DOI":"10.3389\/fcimb.2025.1592977","volume":"15","author":"A Albush","year":"2025","unstructured":"Albush A, Yassine F, Abbas H, Hanna A, Saba E, Bilen M. The impact of Helicobacter pylori infection and eradication therapies on gut microbiota: a systematic review. Front Cell Infect Microbiol 2025;15:1592977. https:\/\/doi.org\/10.3389\/fcimb.2025.1592977.","journal-title":"Front Cell Infect Microbiol"},{"key":"10272_CR52","doi-asserted-by":"publisher","first-page":"aaff1098","DOI":"10.1126\/science.aaf1098","volume":"352","author":"MG Netea","year":"2016","unstructured":"Netea MG, Joosten LA, Latz E et al. Trained immunity: a program of innate immune memory in health and disease. Science 2016;352:aaff1098. https:\/\/doi.org\/10.1126\/science.aaf1098.","journal-title":"Science"},{"key":"10272_CR53","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.3748\/wjg.v29.i15.2222","volume":"29","author":"F Villarroel-Espindola","year":"2023","unstructured":"Villarroel-Espindola F, Ejsmentewicz T, Gonzalez-Stegmaier R, Jorquera RA, Salinas E. Intersections between innate immune response and gastric cancer development. World J Gastroenterol 2023;29:2222\u20132240. https:\/\/doi.org\/10.3748\/wjg.v29.i15.2222.","journal-title":"World J Gastroenterol"},{"key":"10272_CR54","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/978-3-319-50520-6_13","volume":"400","author":"T Shimizu","year":"2017","unstructured":"Shimizu T, Chiba T, Marusawa H. Helicobacter pylori-mediated genetic instability and gastric carcinogenesis. Curr Top Microbiol Immunol 2017;400:305\u2013323. https:\/\/doi.org\/10.1007\/978-3-319-50520-6_13.","journal-title":"Curr Top Microbiol Immunol"},{"key":"10272_CR55","doi-asserted-by":"publisher","first-page":"7951","DOI":"10.1097\/js9.0000000000004273","volume":"112","author":"T Zhang","year":"2026","unstructured":"Zhang T, Hu L, Zhang B, Tang X. Spasmolytic polypeptide-expressing metaplasia: the hidden linchpin in gastric carcinogenesis beyond the Correa cascade. Int J Surg 2026;112:7951\u20138035. https:\/\/doi.org\/10.1097\/js9.0000000000004273.","journal-title":"Int J Surg"},{"key":"10272_CR56","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1053\/j.gastro.2010.04.023","volume":"138","author":"JR Goldenring","year":"2010","unstructured":"Goldenring JR, Nam KT, Wang TC et al. Spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia: time for reevaluation of metaplasias and the origins of gastric cancer. Gastroenterology 2010;138:2207\u20132210. https:\/\/doi.org\/10.1053\/j.gastro.2010.04.023.","journal-title":"Gastroenterology"},{"key":"10272_CR57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3892\/ijo.2025.5830","volume":"68","author":"J Ma","year":"2026","unstructured":"Ma J, Zhan T, Zhang X, Gao W, Zhao S, Li H. Roles of interleukins in spasmolytic polypeptide-expressing metaplasia (Review). Int J Oncol 2026;68:17. https:\/\/doi.org\/10.3892\/ijo.2025.5830.","journal-title":"Int J Oncol"},{"key":"10272_CR58","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1152\/physrev.00042.2025","volume":"106","author":"SK Cornish","year":"2026","unstructured":"Cornish SK, Choi E, Mills JC, Goldenring JR. The origins and progression of pyloric metaplasia following gastric mucosal injury. Physiol Rev 2026;106:2441\u20132471. https:\/\/doi.org\/10.1152\/physrev.00042.2025.","journal-title":"Physiol Rev"},{"key":"10272_CR59","doi-asserted-by":"publisher","unstructured":"Tu R, Zheng H-L, Zheng B, et al (2026) Tff2 marks gastric corpus progenitors that give rise to pyloric metaplasia\/SPEM following injury. Gut (online ahead of print, Apr 14). https:\/\/doi.org\/10.1136\/gutjnl-2025-337839","DOI":"10.1136\/gutjnl-2025-337839"},{"key":"10272_CR60","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1136\/gutjnl-2024-334234","volume":"75","author":"K Togasaki","year":"2026","unstructured":"Togasaki K, Sato T. Decoding intestinal metaplasia: a step towards understanding gastric tumourigenesis. Gut 2026;75:1457\u20131459. https:\/\/doi.org\/10.1136\/gutjnl-2024-334234.","journal-title":"Gut"},{"key":"10272_CR61","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.molmed.2012.07.006","volume":"18","author":"R Barros","year":"2012","unstructured":"Barros R, Freund JN, David L, Almeida R. Gastric intestinal metaplasia revisited: function and regulation of CDX2. Trends Mol Med 2012;18:555\u2013563. https:\/\/doi.org\/10.1016\/j.molmed.2012.07.006.","journal-title":"Trends Mol Med"},{"key":"10272_CR62","doi-asserted-by":"publisher","first-page":"113771","DOI":"10.3748\/wjg.v32.i10.113771","volume":"32","author":"JS Wen","year":"2026","unstructured":"Wen JS, Pan ZW, Yao XD, Liu YQ, Zhu YD. Pristimerin ameliorates spasmolytic polypeptide-expressing metaplasia by modulating Cdkn1c (p57)-mediated glycolytic reprogramming. World J Gastroenterol 2026;32:113771. https:\/\/doi.org\/10.3748\/wjg.v32.i10.113771.","journal-title":"World J Gastroenterol"},{"key":"10272_CR63","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/gut.2006.106666","volume":"56","author":"M Rugge","year":"2007","unstructured":"Rugge M, Meggio A, Pennelli G et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007;56:631\u2013636. https:\/\/doi.org\/10.1136\/gut.2006.106666.","journal-title":"Gut"},{"key":"10272_CR64","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.gie.2009.12.029","volume":"71","author":"LG Capelle","year":"2010","unstructured":"Capelle LG, de Vries AC, Haringsma J et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010;71:1150\u20131158. https:\/\/doi.org\/10.1016\/j.gie.2009.12.029.","journal-title":"Gastrointest Endosc"},{"key":"10272_CR65","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.dld.2025.04.047","volume":"57","author":"P Marcos","year":"2025","unstructured":"Marcos P, Gon\u00e7alves N, Gama J et al. Standardizing endoscopic protocols increases detection of gastric cancer during surveillance of patients with precancerous conditions: a systematic review and meta-analysis. Dig Liver Dis 2025;57:1588\u20131602. https:\/\/doi.org\/10.1016\/j.dld.2025.04.047.","journal-title":"Dig Liver Dis"},{"key":"10272_CR66","doi-asserted-by":"publisher","first-page":"175628482513254","DOI":"10.1177\/17562848251325461","volume":"18","author":"H Benites-Go\u00f1i","year":"2025","unstructured":"Benites-Go\u00f1i H, Cabrera-Hinojosa D, Latorre G et al. OLGA and OLGIM staging systems on the risk assessment of gastric cancer: a systematic review and meta-analysis of prospective cohorts. Therap Adv Gastroenterol 2025;18:17562848251325460. https:\/\/doi.org\/10.1177\/17562848251325461.","journal-title":"Therap Adv Gastroenterol"},{"key":"10272_CR67","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1056\/nejmoa1708423","volume":"378","author":"IJ Choi","year":"2018","unstructured":"Choi IJ, Kook MC, Kim YI et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med 2018;378:1085\u20131095. https:\/\/doi.org\/10.1056\/nejmoa1708423.","journal-title":"N Engl J Med"},{"key":"10272_CR68","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4166\/kjg.2018.72.3.104","volume":"72","author":"K Yoon","year":"2018","unstructured":"Yoon K, Kim N. Reversibility of atrophic gastritis and intestinal metaplasia by eradication of Helicobacter pylori. Korean J Gastroenterol 2018;72:104\u2013115. https:\/\/doi.org\/10.4166\/kjg.2018.72.3.104.","journal-title":"Korean J Gastroenterol"},{"key":"10272_CR69","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2183\/pjab.87.405","volume":"87","author":"K Miki","year":"2011","unstructured":"Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels \u2014 \u2018ABC method.\u2019 Proc Jpn Acad Ser B Phys Biol Sci 2011;87:405\u2013414. https:\/\/doi.org\/10.2183\/pjab.87.405.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10272_CR70","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/nu17010142","volume":"17","author":"A Zaramella","year":"2025","unstructured":"Zaramella A, Arcidiacono D, Duci M et al. Predictive value of a gastric microbiota dysbiosis test for stratifying cancer risk in atrophic gastritis patients. Nutrients 2025;17:142. https:\/\/doi.org\/10.3390\/nu17010142.","journal-title":"Nutrients"},{"key":"10272_CR71","doi-asserted-by":"publisher","first-page":"e0303421","DOI":"10.1371\/journal.pone.0303421","volume":"19","author":"N Li","year":"2024","unstructured":"Li N, Yang J, Li X et al. Accuracy of artificial intelligence-assisted endoscopy in the diagnosis of gastric intestinal metaplasia: a systematic review and meta-analysis. PLoS One 2024;19:e0303421. https:\/\/doi.org\/10.1371\/journal.pone.0303421.","journal-title":"PLoS One"},{"key":"10272_CR72","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1055\/a-0808-3186","volume":"51","author":"G Esposito","year":"2019","unstructured":"Esposito G, Pimentel-Nunes P, Angeletti S et al. Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study. Endoscopy 2019;51:515\u2013521. https:\/\/doi.org\/10.1055\/a-0808-3186.","journal-title":"Endoscopy"},{"key":"10272_CR73","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1053\/j.gastro.2025.12.020","volume":"170","author":"Z Dong","year":"2026","unstructured":"Dong Z, Wu L, Du H et al. Effect of a computer-aided device for detecting gastric neoplasms: a multicenter, randomized controlled trial. Gastroenterology 2026;170:1518\u20131532. https:\/\/doi.org\/10.1053\/j.gastro.2025.12.020.","journal-title":"Gastroenterology"},{"key":"10272_CR74","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/gutjnl-2024-333029","volume":"73","author":"M Dinis-Ribeiro","year":"2024","unstructured":"Dinis-Ribeiro M, Shah S, El-Serag H et al. The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines. Gut 2024;73:1607\u20131617. https:\/\/doi.org\/10.1136\/gutjnl-2024-333029.","journal-title":"Gut"},{"key":"10272_CR75","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/jjco\/hyy077","volume":"48","author":"C Hamashima","year":"2018","unstructured":"Hamashima C. Update version of the Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 2018;48:673\u2013683. https:\/\/doi.org\/10.1093\/jjco\/hyy077.","journal-title":"Jpn J Clin Oncol"},{"key":"10272_CR76","doi-asserted-by":"publisher","first-page":"e13120","DOI":"10.1111\/hel.13120","volume":"29","author":"A Kowada","year":"2024","unstructured":"Kowada A. Cost-effectiveness of population-based Helicobacter pylori screening with eradication for optimal age of implementation. Helicobacter 2024;29:e13120. https:\/\/doi.org\/10.1111\/hel.13120.","journal-title":"Helicobacter"},{"key":"10272_CR77","doi-asserted-by":"publisher","first-page":"709","DOI":"10.14309\/ajg.0000000000003350","volume":"120","author":"DR Morgan","year":"2025","unstructured":"Morgan DR, Corral JE, Li D, Montgomery EA, Riquelme A, Kim JJ, Sauer B, Shah SC. ACG clinical guideline: diagnosis and management of gastric premalignant conditions. Am J Gastroenterol 2025;120:709\u2013737. https:\/\/doi.org\/10.14309\/ajg.0000000000003350.","journal-title":"Am J Gastroenterol"},{"key":"10272_CR78","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/gutjnl-2025-335823","volume":"75","author":"WK Leung","year":"2026","unstructured":"Leung WK, Ang TL, Chiu PWY et al. Asian Pacific Association of Gastroenterology task force recommendations on surveillance for Helicobacter pylori associated gastric premalignant conditions. Gut 2026;75:685\u2013704. https:\/\/doi.org\/10.1136\/gutjnl-2025-335823.","journal-title":"Gut"},{"key":"10272_CR79","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/gutjnl-2011-300154","volume":"61","author":"BC Wong","year":"2012","unstructured":"Wong BC, Zhang L, Ma JL et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut 2012;61:812\u2013818. https:\/\/doi.org\/10.1136\/gutjnl-2011-300154.","journal-title":"Gut"},{"key":"10272_CR80","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1046\/j.1365-2036.2000.00841.x","volume":"14","author":"A Zullo","year":"2000","unstructured":"Zullo A, Rinaldi V, Hassan C et al. Ascorbic acid and intestinal metaplasia in the stomach: a prospective, randomized study. Aliment Pharmacol Ther 2000;14:1303\u20131309. https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00841.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"10272_CR81","first-page":"543","volume":"6","author":"YV Bukin","year":"1997","unstructured":"Bukin YV, Draudin-Krylenko VA, Kuvshinov YP et al. Decrease of ornithine decarboxylase activity in premalignant gastric mucosa and regression of small intestinal metaplasia in patients supplemented with high doses of vitamin E. Cancer Epidemiol Biomarkers Prev 1997;6:543\u2013546.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10272_CR82","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12876-022-02390-y","volume":"22","author":"J Lei","year":"2022","unstructured":"Lei J, Ren F, Li W, Guo X, Liu Q, Gao H, Pang Y, He Y, Guo J, Zeng J. Use of folic acid supplementation to halt and even reverse the progression of gastric precancerous conditions: a meta-analysis. BMC Gastroenterol 2022;22:370. https:\/\/doi.org\/10.1186\/s12876-022-02390-y.","journal-title":"BMC Gastroenterol"},{"key":"10272_CR83","doi-asserted-by":"publisher","first-page":"1409001","DOI":"10.3389\/fphar.2024.1409001","volume":"15","author":"J Xie","year":"2024","unstructured":"Xie J, Liang X, Xie F et al. Rabeprazole suppressed gastric intestinal metaplasia through activation of GPX4-mediated ferroptosis. Front Pharmacol 2024;15:1409001. https:\/\/doi.org\/10.3389\/fphar.2024.1409001.","journal-title":"Front Pharmacol"},{"key":"10272_CR84","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/1751-2980.13251","volume":"25","author":"TH Zou","year":"2024","unstructured":"Zou TH, Gao QY, Liu SD et al. Effectiveness and safety of Moluodan in the treatment of precancerous lesions of gastric cancer: a randomized clinical trial. J Dig Dis 2024;25:27\u201335. https:\/\/doi.org\/10.1111\/1751-2980.13251.","journal-title":"J Dig Dis"},{"key":"10272_CR85","doi-asserted-by":"publisher","first-page":"1693427","DOI":"10.3389\/fphar.2025.1693427","volume":"16","author":"Y Wu","year":"2025","unstructured":"Wu Y, Hu L. Therapeutic effect and safety of Wei-Fu-Chun in the treatment of chronic atrophic gastritis: a network meta-analysis. Front Pharmacol 2025;16:1693427. https:\/\/doi.org\/10.3389\/fphar.2025.1693427.","journal-title":"Front Pharmacol"},{"key":"10272_CR86","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.3748\/wjg.15.2731","volume":"15","author":"LJ Zhang","year":"2009","unstructured":"Zhang LJ, Wang SY, Huo XH et al. Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions. World J Gastroenterol 2009;15:2731\u20132738. https:\/\/doi.org\/10.3748\/wjg.15.2731.","journal-title":"World J Gastroenterol"},{"key":"10272_CR87","doi-asserted-by":"publisher","first-page":"e2022062","DOI":"10.4178\/epih.e2022062","volume":"44","author":"SK Park","year":"2022","unstructured":"Park SK, Chung Y, Oh C-M, Ryoo J-H, Jung JY. The influence of the dietary intake of vitamin C and vitamin E on the risk of gastric intestinal metaplasia in a cohort of Koreans. Epidemiol Health 2022;44:e2022062. https:\/\/doi.org\/10.4178\/epih.e2022062.","journal-title":"Epidemiol Health"},{"key":"10272_CR88","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/1751-2980.13193","volume":"24","author":"JY Fang","year":"2023","unstructured":"Fang JY, Du YQ, Liu WZ et al. Guidelines for diagnosis and treatment of chronic gastritis in China (2022, Shanghai). J Dig Dis 2023;24:150\u2013180. https:\/\/doi.org\/10.1111\/1751-2980.13193.","journal-title":"J Dig Dis"},{"key":"10272_CR89","doi-asserted-by":"publisher","first-page":"e0284411","DOI":"10.1371\/journal.pone.0284411","volume":"18","author":"L Wang","year":"2023","unstructured":"Wang L, Ding X, Li P et al. Efficacy and safety of Weifuchun tablet for chronic atrophic gastritis: a systematic review and meta-analysis. PLoS One 2023;18:e0284411. https:\/\/doi.org\/10.1371\/journal.pone.0284411.","journal-title":"PLoS One"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10272-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10272-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10272-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T17:12:45Z","timestamp":1791738765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10272-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,11]]},"references-count":89,"alternative-id":["10272"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10272-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,11]]},"assertion":[{"value":"20 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AI-assisted language editing tools were used to improve readability and clarity during manuscript preparation. All AI-generated suggestions were reviewed and approved by the authors. The scientific content, analysis, and conclusions remain the sole intellectual work of the authors.","order":2,"name":"Ethics","label":"AID","group":{"name":"EthicsHeading","label":"Declarations"}}]}}